Routine serum C-reactive protein and stroke outcome after intravenous thrombolysis
- 20 February 2014
- journal article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 130 (5) , 305-311
Abstract
The clinical usefulness of blood biomarkers in acute stroke is not yet fully established, especially after thrombolytic therapy. Our aim was to investigate the association between routine serum C-reactive protein (CRP) measured within 24 h after admission and outcome in ischaemic stroke patients treated with intravenous thrombolysis, adjusting for a history of recent infection. We analysed the data of consecutive stroke patients who received intravenous alteplase in our centre between October 2003 and December 2011, collected in a detailed prospective registry. Routine serum CRP was measured within 24 h from admission; concentration >5 ng/ml was considered elevated. Serum CRP was measured in 341 of 406 stroke patients treated with alteplase. Patients with elevated CRP (135/341, 42.5%) compared to those with normal CRP values, were significantly older, more frequently presented with a preexisting disability, comorbidities and suffered more severe strokes. They had a higher proportion of symptomatic intracranial haemorrhage according to ECASS II definition (7.2% vs 1.6%, P = 0.010), higher 3-month mortality (25.6% vs 11.3%, P = 0.001), and were less frequently alive and independent after 3 months (45.9% vs 63.7%, P = 0.002). However, those associations were not confirmed after adjustment for age, stroke severity, diabetes, congestive heart failure, lack of prestroke disability and signs of recent infection. According to our findings, elevated routine serum CRP measured within 24 h after admission does not seem to independently affect the outcome in patients receiving intravenous thrombolysis for stroke. However, further studies of blood samples taken directly before the treatment are needed.Keywords
This publication has 42 references indexed in Scilit:
- C-Reactive Protein and Nitric Oxide Levels in Ischemic Stroke and Its Subtypes: Correlation with Clinical OutcomeInflammation, 2011
- C-reactive protein in the very early phase of acute ischemic stroke: association with poor outcome and deathJournal of Neurology, 2009
- Blood Markers for the Prognosis of Ischemic StrokeStroke, 2009
- Admission C – reactive protein after acute ischemic stroke is associated with stroke severity and mortality: The 'Bergen stroke study'BMC Neurology, 2009
- Associations of Inflammatory and Haemostatic Biomarkers with Poor Outcome in Acute Ischaemic StrokeCerebrovascular Diseases, 2009
- The use of high-sensitivity assays for C-reactive protein in clinical practiceNature Clinical Practice Cardiovascular Medicine, 2008
- Variability of the systemic acute phase response after ischemic strokeJournal of the Neurological Sciences, 2006
- Evaluation of C-Reactive Protein Measurement for Assessing the Risk and Prognosis in Ischemic StrokeStroke, 2005
- C-Reactive Protein and White Blood Cell Count Increases in the First 24 Hours after Acute StrokeCerebrovascular Diseases, 2004
- C-Reactive Protein in Ischemic StrokeStroke, 2001